Tag: biopharma leader
It’s a no go – Pfizer and Allergan will not merge
Last November, global biopharmaceutical giant Pfizer and Botox maker Allergan announced an all-stock $160 billion merger that would have resulted in the creation of...
Pfizer, Allergan merger to create the world’s biggest pharmaceutical company
Global biopharmaceutical giant Pfizer and Botox maker Allergan have announced an all-stock $160 billion merger that will result in the creation of the world’s...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
